Matthew E. Sloan

3.6k citations

57 papers · 2.6k indexed · 2 hit papers · h-index 23

Impact in

Catalysis top 2%
- Ammonia Synthesis and Nitrogen Reduction
Process Chemistry and Technology top 2%

Papers in

General Decision Sciences 3
Pharmacology 13
- Cannabis and Cannabinoid Research 10

Co-authors: Ian Manners Anne Staubitz Alasdair P. M. Robertson Ben Armstrong Alison D. McDonald Joshua L. Gowin Timothy J. Clark Vijay A. Ramchandani
Journals: American Journal of Public Health (3 papers)Psychopharmacology (3 papers)Addiction Biology (3 papers)American Journal of Psychiatry (2 papers)Journal of the American Chemical Society (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Matthew E. Sloan

51 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Emotion regulation in substance use disorders: a systematic review and meta‐analysis 2022 · 118 citations

Peers

Countries citing papers authored by Matthew E. Sloan

Since Specialization

Citations

This map shows the geographic impact of Matthew E. Sloan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Sloan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Sloan more than expected).

Fields of papers citing papers by Matthew E. Sloan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew E. Sloan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Sloan. The network helps show where Matthew E. Sloan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Matthew E. Sloan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew E. Sloan Line = papers co-authored together Matthew E. Sloan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Deep Brain Stimulation for Substance Use Disorder: Case Report of Fentanyl Use Disorder and Review of the Literature Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·Andrew Yang, James MacKillop, Alexandre Boutet, Anton Fomenko, Artur Vetkas, Matthew E. Sloan, Can Sarica, Brendan Santyr, Agustin Jauregu, S Villafuerte, Jürgen Germann, Ivan Skelin, Luka Milosevic, Benjamin Davidson, Suneil K. Kalia, Taufik A. Valiante, Andrés M. Lozano, Victor M. Tang	2025	0
2	Symptom-Triggered Alcohol Withdrawal Management Delivered Over Telemedicine Journal of Addiction Medicine ·Matthew E. Sloan, シゲキカジ, Frano Violich, Ayesha Zeb, J M Hemstreet, Xiaozhu Kang, M.S. Luong, Christian S. Hendershot, Meldon Kahan, X. Li, Bernard Le Foll, H. R. Nindhito, Marcos Sanches, 中村暢宏, Lena C. Quilty, Rodrigo Augusto Ricco, Victor M. Tang, Nikki Bozinoff	2025	0
3	Body Mass Index Is Inversely Associated With Level of Response to Alcohol: Role of Total Body Water Journal of Studies on Alcohol and Drugs ·Grant A. Umeda, B Stangl, Matthew E. Sloan, U. Rössner, 羊波, Paule V. Joseph, Melanie L. Schwandt, Marta Yanina Pepino, Nancy Diazgranados, Vijay A. Ramchandani	2025	1
4	26. Dopamine Abnormalities in the Substantia Nigra of Diverse and Comorbid Substance Users are Linked to Stimulant Use Disorder Severity and Executive Dysfunction Biological Psychiatry ·Guosheng Duan, 利朗唐木, Colin Hawco, Isabelle Boileau, Philip Gerretsen, Victor M. Tang, Matthew E. Sloan, Brian D. Burne, Dmitrii Kupriyanov, Jeffrey D. Wardell, Etienne Sibille, Lena C. Quilty, Anthony C. Ruocco, Yuliya S. Nikolova	2024	0
5	Neuromodulation for Cannabis Use: A Scoping Review Brain Sciences ·シゲキカジ, Victor M. Tang, 韩暄, Daniel M. Blumberger, Tony P. George, Joshua L. Gowin, Bernard Le Foll, Matthew E. Sloan	2024	1
6	Repetitive transcranial magnetic stimulation for smoking cessation: Next steps for translation and implementation into clinical practice Psychiatry Research ·Victor M. Tang, G. Spiegler, Laurie Zawertailo, Peter Selby, Adina Coroiu, Matthew E. Sloan, Meghan J. Chenoweth, Daniel Z. Buchman, Christine Ibrahim, Daniel M. Blumberger, Bernard Le Foll	2023	4
7	GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential Frontiers in Neural Circuits ·Hamzah Saei, 段六生, Victor M. Tang, Matthew E. Sloan, Yuliya S. Nikolova, 利朗唐木, Anthony C. Ruocco, Kevin D. Shield, Daphne Voineskos, Daniel M. Blumberger, Isabelle Boileau, Nikki Bozinoff, Philip Gerretsen, Érica Leandro Marciano Vieira, Osnat C. Melamed, Etienne Sibille, Lena C. Quilty, Thomas D. Prévot	2023	22
8	Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies Psychopharmacology ·Frano Violich, S. Handa, シゲキカジ, Tony P. George, Bernard Le Foll, Christian S. Hendershot, Matthew E. Sloan	2023	6
9	Endocannabinoid System Biomarkers in Alzheimer's Disease Cannabis and Cannabinoid Research ·Pâmela C.L. Ferreira, Bruna Bellaver, Guilherme Povala, Wagner S. Brum, Cécile Tissot, Atef Badji, Matthew E. Sloan, Andréa Lessa Benedet, Pedro Rosa‐Neto, Nicholas J. Ashton, Tharick A. Pascoal, Antoine Leuzy, Eduardo R. Zimmer	2022	0
10	Modeling ability to resist alcohol in the human laboratory: A pilot study SHILAP Revista de lepidopterología ·Matthew E. Sloan, Marla Adams, Alfonso Vicencio, James Morris, R. W. Teiss, Lou Ya, Molly O' Meara Sheehan, B Stangl, Joshua L. Gowin, Bernadiaz Danuarta, Nancy Diazgranados, Sherry A. McKee, Andrew J. Waters, Vijay A. Ramchandani	2022	2
11	Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies Acta Pharmacologica Sinica ·Matthew E. Sloan, Xingyu Tang, Joshua L. Gowin, Vijay A. Ramchandani, Bernard Le Foll	2018	33
12	The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption Neuropsychopharmacology ·Matthew E. Sloan, 贺君祝, Joshua L. Gowin, Maddi Matassarin, Hui Sun, B Stangl, Vijay A. Ramchandani	2018	18
13	The endocannabinoid system as a target for addiction treatment: Trials and tribulations Neuropharmacology ·Matthew E. Sloan, Joshua L. Gowin, Vijay A. Ramchandani, Yasmin L. Hurd, Bernard Le Foll	2017	69
14	The Effects of 'Girl-Friendly' Schools: Evidence from the Bright School Construction Program in Burkina Faso SSRN Electronic Journal ·Harounan Kazianga, Leigh Linden, Matthew E. Sloan	2012	3
15	Nonsteroidal Antiinflammatory Drug Use and Breast Cancer Risk: Subgroup Findings American Journal of Epidemiology ·Victoria A. Kirsh, Nancy Kreiger, Michelle Cotterchio, Matthew E. Sloan, Bernhard Theis	2007	40
16	Attrition and Non-Compliance in Secondary Stroke Prevention Trials Neuroepidemiology ·Dibakar Chakrabarty, Matthew E. Sloan, Sue E. Leurgans, Rema Raman, Yvonne Harris, Philip B. Gorelick	2004	22
17	The risk of breast cancer following reproductive surgery European Journal of Cancer ·Nancy Kreiger, Matthew E. Sloan, Michelle Cotterchio, Victoria A. Kirsh	1999	44
18	Surgical procedures associated with risk of ovarian cancer International Journal of Epidemiology ·Nancy Kreiger, Matthew E. Sloan, Michelle Cotterchio, Peter G. Parsons	1997	54
19	Cigarette, alcohol, and coffee consumption and prematurity. American Journal of Public Health ·Alison D. McDonald, Ben Armstrong, Matthew E. Sloan	1992	140
20	Cigarette, alcohol, and coffee consumption and congenital defects. American Journal of Public Health ·Alison D. McDonald, Ben Armstrong, Matthew E. Sloan	1992	98

About Matthew E. Sloan

Matthew E. Sloan is a scholar working on General Decision Sciences, Pharmacology, Cellular and Molecular Neuroscience, Applied Psychology and Toxicology, having authored 57 papers that have together received 2.6k indexed citations. Recurring topics across this work include Substance Abuse Treatment and Outcomes (13 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Cannabis and Cannabinoid Research (10 papers), Alcohol Consumption and Health Effects (8 papers), Hydrogen Storage and Materials (5 papers), Mental Health Research Topics (5 papers), Asymmetric Hydrogenation and Catalysis (4 papers) and Homelessness and Social Issues (4 papers). The work is most often cited by research in Catalysis (425 citations), Process Chemistry and Technology (171 citations), Inorganic Chemistry (628 citations), Energy Engineering and Power Technology (109 citations) and Obstetrics and Gynecology (203 citations). Matthew E. Sloan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Ian Manners, Anne Staubitz, Alasdair P. M. Robertson, Ben Armstrong, Alison D. McDonald, Joshua L. Gowin, Timothy J. Clark, Vijay A. Ramchandani, Nancy Kreiger and Guy C. Lloyd‐Jones. Their work appears in journals such as American Journal of Public Health, Psychopharmacology, Addiction Biology, American Journal of Psychiatry and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact